Chemoimmunotherapy Followed by Surgery for Oligometastatic Esophagogastric Cancer: (TORO Protocol)

Clinical trial NCT06668454 · RECRUITING

Trial details

NCT number: NCT06668454
Sponsor: University Health Network, Toronto
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Esophageal Cancer Gastric Cancer Oligometastatic Disease

Start date: 2025-05-09
Primary completion: 2035-05-09
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.